GH Q3 2020 Earnings — Guardant Health, Inc. Revenue & Financial Results | Market Cap Arena

GHGuardant Health, Inc.

$12B

Q3 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$75M+22.5% YoY

Gross Profit

$53M71.6% margin

Operating Income

-$74M-99.6% margin

Net Income

-$78M-104.2% margin

EPS (Diluted)

$-0.78

QoQ Revenue Growth

+12.4%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$18M

Stock-Based Comp.

$55M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$114M

Stockholders' Equity

$1.1B

Cash & Equivalents

$143M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$75M	$61M	+22.5%
Gross Profit	$53M	$42M	+26.1%
Operating Income	-$74M	-$17M	-324.9%
Net Income	-$78M	-$13M	-507.3%

Geographic Segments

UNITED STATES

$66M88%

Non-US

$9M12%